Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.

Navailles S, Bioulac B, Gross C, De Deurwaerdère P.

Neurobiol Dis. 2010 Apr;38(1):136-43. doi: 10.1016/j.nbd.2010.01.012. Epub 2010 Jan 22.

PMID:
20096781
3.

Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter.

Arai A, Tomiyama M, Kannari K, Kimura T, Suzuki C, Watanabe M, Kawarabayashi T, Shen H, Shoji M.

Synapse. 2008 Aug;62(8):632-5. doi: 10.1002/syn.20535.

PMID:
18509855
4.

High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.

Navailles S, Benazzouz A, Bioulac B, Gross C, De Deurwaerdère P.

J Neurosci. 2010 Feb 10;30(6):2356-64. doi: 10.1523/JNEUROSCI.5031-09.2010.

6.

Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.

Navailles S, Bioulac B, Gross C, De Deurwaerdère P.

Neurobiol Dis. 2011 Feb;41(2):585-90. doi: 10.1016/j.nbd.2010.11.007. Epub 2010 Nov 16.

PMID:
21092759
7.

MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats.

Jonkers N, Sarre S, Ebinger G, Michotte Y.

Eur J Pharmacol. 2000 Nov 3;407(3):281-91.

PMID:
11068024
8.

L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.

Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA.

J Neurochem. 2010 Mar;112(6):1465-76. doi: 10.1111/j.1471-4159.2009.06556.x. Epub 2009 Dec 24.

9.
10.

Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.

Carta M, Lindgren HS, Lundblad M, Stancampiano R, Fadda F, Cenci MA.

J Neurochem. 2006 Mar;96(6):1718-27.

11.
12.

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

Carta M, Carlsson T, Kirik D, Björklund A.

Brain. 2007 Jul;130(Pt 7):1819-33. Epub 2007 Apr 23.

PMID:
17452372
13.

L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.

Miguelez C, Navailles S, Delaville C, Marquis L, Lagière M, Benazzouz A, Ugedo L, De Deurwaerdère P.

Eur Neuropsychopharmacol. 2016 Aug;26(8):1297-309. doi: 10.1016/j.euroneuro.2016.05.004. Epub 2016 May 24.

PMID:
27234917
14.

Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats.

Carta AR, Pinna A, Tronci E, Morelli M.

Neurology. 2003 Dec 9;61(11 Suppl 6):S39-43.

PMID:
14663008
15.

Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.

Kääriäinen TM, García-Horsman JA, Piltonen M, Huotari M, Männistö PT.

Basic Clin Pharmacol Toxicol. 2008 Mar;102(3):300-7. Epub 2007 Oct 31.

16.

MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats.

Jonkers N, Sarre S, Ebinger G, Michotte Y.

Brain Res. 2002 Feb 1;926(1-2):149-55.

PMID:
11814417
18.

Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.

Sader-Mazbar O, Loboda Y, Rabey MJ, Finberg JP.

Br J Pharmacol. 2013 Nov;170(5):999-1013. doi: 10.1111/bph.12349.

19.

Chronic intermittent L-DOPA treatment induces changes in dopamine release.

Lundblad M, af Bjerkén S, Cenci MA, Pomerleau F, Gerhardt GA, Strömberg I.

J Neurochem. 2009 Feb;108(4):998-1008. doi: 10.1111/j.1471-4159.2008.05848.x.

20.

In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.

Sarre S, Lanza M, Makovec F, Artusi R, Caselli G, Michotte Y.

Eur J Pharmacol. 2008 Apr 28;584(2-3):297-305. doi: 10.1016/j.ejphar.2008.02.027. Epub 2008 Feb 19.

PMID:
18342306

Supplemental Content

Support Center